Indian Pharmacopoeia 2018 - Addendum 2021

Salient Features: Addendum 2021 to IP 2018 contains a total of 66 new drug monographs [including 59 Chemical, 05 Herbal Products, and 02 Blood-Related Products] and 04 new General Chapters. In addition, a total of 260 monograph amendments have also been included in the content of the IP Addendum 2021 that would further upgrade the quality of drug standards included in the IP. The effective date of this Addendum has been kept as 1st October 2021 and a total period of six months is being given to the stakeholders to implement the new standards included therein.